Laman UtamaPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
$1.12
Selepas Waktu Dagangan:(0.89%)+0.0100
$1.13
Tutup: 12 Dis, 7:21:13 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.14
Julat hari
$1.12 - $1.17
Julat tahun
$0.97 - $9.79
Permodalan pasaran
12.06J USD
Bilangan Purata
6.00J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
01net
16 jam lalu
System1 Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
1.15%
MarketWatch
27 minit lalu
Walmart was too late for a Nasdaq-100 spot — but these 6 stocks made the cut
0.30%
1.91%
6.56%
1.02%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 1.32J | 39.96% |
Pendapatan bersih | -2.39J | -56.96% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.44 | — |
EBITDA | -2.50J | -57.51% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 10.70J | 98.61% |
Jumlah aset | 11.50J | 96.16% |
Jumlah liabiliti | 1.67J | 81.28% |
Jumlah ekuiti | 9.84J | — |
Syer tertunggak | 10.76J | — |
Harga kepada buku | 0.67 | — |
Pulangan pada aset | -54.92% | — |
Pulangan pada modal | -62.83% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -2.39J | -56.96% |
Tunai daripada operasi | -2.08J | -6.76% |
Tunai daripada pelaburan | -7.00K | — |
Tunai daripada pembiayaan | 2.02J | -23.55% |
Perubahan bersih dalam tunai | -70.00K | -110.12% |
Aliran tunai bebas | -1.27J | 11.16% |
Perihal
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Diasaskan
2011
Tapak web
Pekerja
5
